Middle East and Africa Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Botulinum toxin A and Botulinum toxin B), Application (Medical and Aesthetic), and End User (Speciality and Dermatology Clinics, Hospitals and Clinics, and Others)
The Middle East & Africa (MEA) botulinum toxin market is expected to reach US$ 288.2 million by 2028 from US$ 199.6 million in 2021. The market is estimated to grow at a CAGR of 5.4% from 2021 to 2028.
In recent years, non-invasive cosmetic treatments have gained immense popularity due to minimal downtime, no scarring, low cost, greater accuracy, and fewer complications compared to open procedures. Due to lower post-treatment downtime, the demand for these procedures is significantly high among patients. Moreover, several manufacturers are working on offering more advanced non-invasive cosmetic treatment products. Therefore, the rising awareness about non-invasive cosmetic procedures and the increasing availability of user-friendly and technologically advanced non-invasive cosmetic treatment products are boosting the growth of the MEA botulinum toxin market.
With these new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the botulinum toxin market at a promising CAGR during the forecast period.
Middle East & Africa Botulinum Toxin Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
Middle East & Africa Botulinum Toxin Market Segmentation
By Product Type
- Type A Botulinum Toxin
- Type B Botulinum Toxin
By Application
- Medical
- Chronic Migraine
- Muscle Spasm
- Over Reactive Bladder
- Hyperhidrosis
- Others
- Aesthetic
- Crow’s Feet
- Forehead Lines
- Frown Lines/ Glabellar
- Square Jaw/ Masseter
- Others
By End-User
- Specialty And Dermatology Clinics
- Hospitals And Clinics
- Others
By Country
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Companies Mentioned
- AbbVie Inc.
- Merz Pharma
- Sanofi
- Galderma
- Candela Medica
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Botulinum Toxin Market – By Product Type
1.3.2 Middle East & Africa Botulinum Toxin Market – By Application
1.3.3 Middle East & Africa Botulinum Toxin Market – By End User
1.3.4 Middle East & Africa Botulinum Toxin Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Botulinum Toxin Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
4.3 Experts Opinion
5. Botulinum Toxin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Aesthetics Procedures and Use of Botulinum Toxin
5.1.2 Rising Number of Non-invasive Cosmetic Procedures
5.2 Market Restraints
5.2.1 Side-Effects of Botulinum Toxin
5.3 Market Opportunities
5.3.1 Increasing Therapeutic Applications of Botulinum Toxin
5.4 Future Trends
5.4.1 Rise in Product Approvals
5.5 Impact Analysis
6. Botulinum Toxin Market– Middle East & Africa Analysis
6.1 Middle East & Africa Botulinum Toxin Market Revenue Forecast and Analysis
7. Middle East & Africa Botulinum Toxin Market Revenue and Forecasts To 2028– by Product Type
7.1 Overview
7.2 Middle East & Africa Botulinum Toxin Market Revenue Share, by Product Type (2020 and 2028)
7.3 Type A Botulinum Toxin
7.3.1 Overview
7.3.2 Type A Botulinum Toxin: Middle East & Africa Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Type B Botulinum Toxin
7.4.1 Overview
7.4.2 Type B Botulinum Toxin: Middle East & Africa Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Botulinum Toxin Market Analysis – By Application
8.1 Overview
8.2 Middle East & Africa Botulinum Toxin Market Revenue Share, by Application (2020 and 2028)
8.3 Medical
8.3.1 Overview
8.3.2 Medical: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Chronic Migraine
8.3.2.1.1 Overview
8.3.2.1.2 Chronic Migraine: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Muscle Spasm
8.3.2.2.1 Overview
8.3.2.2.2 Muscle Spasm: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Over Reactive Bladder
8.3.2.3.1 Overview
8.3.2.3.2 Over Reactive Bladder: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Hyperhidrosis
8.3.2.4.1 Overview
8.3.2.4.2 Hyperhidrosis: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Crow’s Feet
8.4.2.1.1 Overview
8.4.2.1.2 Crow’s Feet: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.2 Forehead Lines
8.4.2.2.1 Overview
8.4.2.2.2 Forehead Lines: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.3 Frown Lines/ Glabellar
8.4.2.3.1 Overview
8.4.2.3.2 Frown Lines/ Glabellar: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.4 Square Jaw/ Masseter
8.4.2.4.1 Overview
8.4.2.4.2 Square Jaw/ Masseter: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.5 Others
8.4.2.5.1 Overview
8.4.2.5.2 Others: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Botulinum Toxin Market Analysis – By End User
9.1 Overview
9.2 Middle East & Africa Botulinum Toxin Market Revenue Share, by End User (2020 and 2028)
9.3 Specialty and Dermatology Clinics
9.3.1 Overview
9.3.2 Specialty and Dermatology Clinics: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Clinics
9.4.1 Overview
9.4.2 Hospitals and Clinics: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Middle East & Africa botulinum toxin market– revenue and forecast to 2028 (us$ million)
10. Botulinum Toxin Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 Middle East and Africa: Botulinum Toxin Market
10.1.1 Overview
10.1.2 Middle East and Africa: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.1.3 Middle East and Africa: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.4 Middle East and Africa: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.4.1 Middle East and Africa: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.4.2 Middle East and Africa: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.5 Middle East and Africa: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.1.6 Middle East and Africa: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Country (%)
10.1.6.1 Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.2 Saudi Arabia: Botulinum Toxin Market –Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.6.1.3 Saudi Arabia: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.1.3.1 Saudi Arabia: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.1.3.2 Saudi Arabia: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.1.4 Saudi Arabia: Botulinum Toxin Market –Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.6.2 UAE: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 UAE: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.1.6.2.2 UAE: Botulinum Toxin Market Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.6.2.3 UAE: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.2.3.1 UAE: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.2.3.2 UAE: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.2.4 UAE: Botulinum Toxin Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.6.3 South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.2 South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028, By Product Type (US$ Million)
10.1.6.3.3 South Africa: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.3.3.1 South Africa: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.3.3.2 South Africa: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.3.4 South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028, By End User (US$ Million)
10.1.6.4 Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.4.1 Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.4.2 Rest of Middle East and Africa: Botulinum Toxin Market, By Product Type, 2019-2028 (US$ Million)
10.1.6.4.3 Rest of Middle East and Africa: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.4.3.1 Rest of Middle East and Africa: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.4.3.2 Rest of Middle East and Africa: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.4.4 Rest of Middle East and Africa: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
11. Botulinum Toxin Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 AbbVie Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merz Pharma
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sanofi
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Galderma
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Candela Medical
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Middle East and Africa: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 3. Middle East and Africa: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 4. Middle East and Africa: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 5. Middle East and Africa: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia: Botulinum Toxin Market, By Product Type -Revenue and Forecast to 2028 (US$ Million)
Table 7. Saudi Arabia: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 9. Saudi Arabia: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 10. Saudi Arabia: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 11. UAE: Botulinum Toxin Market, By Product Type - Revenue and Forecasts to 2028 (US$ Million)
Table 12. UAE: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. UAE: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 14. UAE: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 15. UAE: Botulinum Toxin Market, By End User - Revenue and Forecasts to 2028 (US$ Million)
Table 16. South Africa: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. South Africa: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 18. South Africa: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 19. South Africa: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 20. South Africa: Botulinum Toxin Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest Of Middle East and Africa: Botulinum Toxin Market, By Product Type- Revenue and Forecasts to 2028 (US$ Million)
Table 22. Rest of Middle East and Africa: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Middle East and Africa: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 24. Rest of Middle East and Africa: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest Of Middle East and Africa: Botulinum Toxin Market, By End User- Revenue and Forecasts to 2028 (US$ Million)
Table 26. Organic Developments Done by Companies
Table 27. Inorganic Developments Done by Companies
Table 28. Glossary of Terms
LIST OF FIGURES
Figure 1. Botulinum Toxin Market Segmentation
Figure 2. Middle East & Africa Botulinum Toxin Market Overview
Figure 3. Type A Botulinum Toxin Segment Held Largest Share of Product Type Segment in Botulinum Toxin Market
Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Middle East & Africa Botulinum Toxin Market, Industry Landscape
Figure 6. Middle East & Africa: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Middle East & Africa Botulinum Toxin Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 9. Middle East & Africa Botulinum Toxin Market Revenue Share, by Product Type (2020 and 2028)
Figure 10. Type A Botulinum Toxin: Middle East & Africa Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Type B Botulinum Toxin: Middle East & Africa Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Middle East & Africa Botulinum Toxin Market Revenue Share, by Application (2020 and 2028)
Figure 13. Medical: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Chronic Migraine: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Muscle Spasm: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Over Reactive Bladder: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Hyperhidrosis: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Aesthetic: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Crow’s Feet: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Forehead Lines: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 22. Frown Lines/ Glabellar: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Square Jaw/ Masseter: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Middle East & Africa Botulinum Toxin Market Revenue Share, by End User (2020 and 2028)
Figure 26. Specialty and Dermatology Clinics: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Hospitals and Clinics: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Middle East & Africa Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Middle East and Africa: Botulinum Toxin Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. Middle East and Africa: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Middle East and Africa: Botulinum Toxin Market -Revenue and Forecasts to 2028, By Country (%)
Figure 32. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. UAE: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 34. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Growth Strategies Done by the Companies in the Market, (%)
- AbbVie Inc.
- Merz Pharma
- Sanofi
- Galderma
- Candela Medical
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa botulinum toxin market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa botulinum toxin market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.